|
Lexicon Genetics Incorporated, based in Woodlands, Texas, is a biopharmaceutical company that is known for its gene knockout technology. The firm discovers and develops small molecule drugs, therapeutic antibodies, and therapeutic proteins. It has employed its gene knockout technology in determining the physiological functions of 5,000 genes. Research efforts are focused on cardiovascular disease, cancer, and on metabolic, immune system, and neurological disorders. Lexicon Genetics is managing 20 drug discovery programs, including those focused on obesity and diabetes, atherosclerosis, inflammation, and cognitive disorders. The firm is working with Genentech, Abgenix, and other companies. It also has established strategic collaborations with research and academic institutions.
|